The rapid diagnostic test (RDT) kits market is booming, projected to reach $25 billion by 2033, driven by rising infectious disease prevalence and advancements in point-of-care diagnostics. Explore market trends, key players (Abbott, Roche, Thermo Fisher), and growth projections in this comprehensive analysis.

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.